| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5500413 | FERRING PHARMS INC | Process for manufacture of 1-deamino-8-D-arginine vasopressin |
Jun, 2013
(10 years ago) | |
| US5763407 | FERRING PHARMS INC | High-purity desmopressin produced in large single batches |
Jun, 2013
(10 years ago) | |
| US5674850 | FERRING PHARMS INC | High purity desmopressin produced in large single batches |
Dec, 2013
(10 years ago) | |
| US7022340 | FERRING PHARMS INC | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
Apr, 2023
(1 year, 1 day ago) | |
Ddavp is owned by Ferring Pharms Inc.
Ddavp contains Desmopressin Acetate.
Ddavp has a total of 4 drug patents out of which 4 drug patents have expired.
Expired drug patents of Ddavp are:
- US5500413
- US5763407
- US5674850
- US7022340
Ddavp is available in solution;nasal, spray, metered;nasal, tablet;oral, injectable;injection dosage forms.
The generics of Ddavp are possible to be released after 30 April, 2023.
Drugs and Companies using DESMOPRESSIN ACETATE ingredient
Treatment: NA
Dosage: SPRAY, METERED;NASAL; TABLET;ORAL; INJECTABLE;INJECTION; SOLUTION;NASAL
How can I launch a generic of DDAVP before it's drug patent expiration?
More Information on Dosage
DDAVP family patents
